BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nadeem A, Ahmad SF, Al-Harbi NO, El-Sherbeeny AM, Al-Harbi MM, Almukhlafi TS. GPR43 activation enhances psoriasis-like inflammation through epidermal upregulation of IL-6 and dual oxidase 2 signaling in a murine model. Cell Signal 2017;33:59-68. [PMID: 28212864 DOI: 10.1016/j.cellsig.2017.02.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alshammari MA, Khan MR, Alsaad AM, Attia SM. S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T+ Itpr3tf/J mice. Cellular Signalling 2018;52:127-36. [DOI: 10.1016/j.cellsig.2018.09.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Nadeem A, Ahmad SF, El-sherbeeny AM, Al-harbi NO, Bakheet SA, Attia SM. Systemic inflammation in asocial BTBR T + tf/J mice predisposes them to increased psoriatic inflammation. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;83:8-17. [DOI: 10.1016/j.pnpbp.2017.12.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
3 He T, Zhang N, Wang L, Wan B, Wang X, Zhang L. GPR43 regulates HBV X protein (HBx)-induced inflammatory response in human LO2 hepatocytes. Biomedicine & Pharmacotherapy 2020;123:109737. [DOI: 10.1016/j.biopha.2019.109737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Al-harbi NO, Nadeem A, Ahmad SF, Alotaibi MR, Alasmari AF, Alanazi WA, Al-harbi MM, El-sherbeeny AM, Ibrahim KE. Short chain fatty acid, acetate ameliorates sepsis-induced acute kidney injury by inhibition of NADPH oxidase signaling in T cells. International Immunopharmacology 2018;58:24-31. [DOI: 10.1016/j.intimp.2018.02.023] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
5 Li LZ, Tao SB, Ma L, Fu P. Roles of short-chain fatty acids in kidney diseases. Chin Med J (Engl) 2019;132:1228-32. [PMID: 30946066 DOI: 10.1097/CM9.0000000000000228] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Alzahrani KS, Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, El-Sherbeeny AM, Alhoshani AR, Alshammari MA, Alotaibi MR, Al-Harbi MM. Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis. Biomed Pharmacother 2019;111:347-58. [PMID: 30593001 DOI: 10.1016/j.biopha.2018.12.060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Li X, Li A, Feng F, Jiang Q, Sun H, Chai Y, Yang R, Wang Z, Hou J, Li R. Effect of the hyaluronic acid-poloxamer hydrogel on skin-wound healing: in vitro and in vivo studies. Animal Model Exp Med 2019;2:107-13. [PMID: 31392303 DOI: 10.1002/ame2.12067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
8 Nadeem A, Al-Harbi NO, Ahmad SF, Ibrahim KE, Siddiqui N, Al-Harbi MM. Glucose-6-phosphate dehydrogenase inhibition attenuates acute lung injury through reduction in NADPH oxidase-derived reactive oxygen species. Clin Exp Immunol 2018;191:279-87. [PMID: 29277898 DOI: 10.1111/cei.13097] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
9 Alhazzani K, Ahmad SF, Al-Harbi NO, Attia SM, Bakheet SA, Sarawi W, Alqarni SA, Algahtani M, Nadeem A. Pharmacological Inhibition of STAT3 by Stattic Ameliorates Clinical Symptoms and Reduces Autoinflammation in Myeloid, Lymphoid, and Neuronal Tissue Compartments in Relapsing-Remitting Model of Experimental Autoimmune Encephalomyelitis in SJL/J Mice. Pharmaceutics 2021;13:925. [PMID: 34206429 DOI: 10.3390/pharmaceutics13070925] [Reference Citation Analysis]
10 Karamani C, Antoniadou IT, Dimou A, Andreou E, Kostakis G, Sideri A, Vitsos A, Gkavanozi A, Sfiniadakis I, Skaltsa H, Papaioannou GT, Rallis MC, Maibach H. Optimization of psoriasis mouse models. J Pharmacol Toxicol Methods 2021;108:107054. [PMID: 33775808 DOI: 10.1016/j.vascn.2021.107054] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wen C, Xie T, Pan K, Deng Y, Zhao Z, Li N, Bian J, Deng X, Zha Y. Acetate attenuates perioperative neurocognitive disorders in aged mice. Aging (Albany NY) 2020;12:3862-79. [PMID: 32139660 DOI: 10.18632/aging.102856] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
12 Zhang C, Chang J, Wu W, Deng Y, Zhou P, Jiang W, Wang C, Huang F. Activation of GPR43 suppresses TNF-α-induced inflammatory response in human fibroblast-like synoviocytes. Arch Biochem Biophys 2020;684:108297. [PMID: 32035098 DOI: 10.1016/j.abb.2020.108297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Schlatterer K, Peschel A, Kretschmer D. Short-Chain Fatty Acid and FFAR2 Activation - A New Option for Treating Infections? Front Cell Infect Microbiol 2021;11:785833. [PMID: 34926327 DOI: 10.3389/fcimb.2021.785833] [Reference Citation Analysis]
14 Yadav K, Singh D, Singh MR. Protein biomarker for psoriasis: A systematic review on their role in the pathomechanism, diagnosis, potential targets and treatment of psoriasis. Int J Biol Macromol 2018;118:1796-810. [PMID: 30017989 DOI: 10.1016/j.ijbiomac.2018.07.021] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
15 Recio C, Lucy D, Iveson P, Iqbal AJ, Valaris S, Wynne G, Russell AJ, Choudhury RP, O'callaghan C, Monaco C, Greaves DR. The Role of Metabolite-Sensing G Protein-Coupled Receptors in Inflammation and Metabolic Disease. Antioxidants & Redox Signaling 2018;29:237-56. [DOI: 10.1089/ars.2017.7168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, Alqahtani F, Alanazi WA, Mahmood HM, Alsanea S, Attia SM. Bruton's tyrosine kinase inhibition attenuates oxidative stress in systemic immune cells and renal compartment during sepsis-induced acute kidney injury in mice. Int Immunopharmacol 2021;90:107123. [PMID: 33168411 DOI: 10.1016/j.intimp.2020.107123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Yadav K, Singh D, Singh MR. Novel archetype in psoriasis management bridging molecular dynamics in exploring novel therapies. Eur J Pharmacol 2021;907:174254. [PMID: 34118225 DOI: 10.1016/j.ejphar.2021.174254] [Reference Citation Analysis]
18 Rudolf J, Raad H, Taieb A, Rezvani HR. NADPH Oxidases and Their Roles in Skin Homeostasis and Carcinogenesis. Antioxidants & Redox Signaling 2018;28:1238-61. [DOI: 10.1089/ars.2017.7282] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
19 Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, Alqahtani F, As Sobeai HM, Alotaibi MR. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice. Biochimie 2020;179:146-56. [PMID: 33007409 DOI: 10.1016/j.biochi.2020.09.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Nadeem A, Ahmad SF, Al-Harbi NO, El-Sherbeeny AM, Alasmari AF, Alanazi WA, Alasmari F, Ibrahim KE, Al-Harbi MM, Bakheet SA, Attia SM. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells. Int Immunopharmacol 2020;80:106215. [PMID: 31982823 DOI: 10.1016/j.intimp.2020.106215] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
21 Li Q, Liu W, Gao S, Mao Y, Xin Y. Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist. BMC Immunol 2021;22:11. [PMID: 33509093 DOI: 10.1186/s12865-021-00401-3] [Reference Citation Analysis]